SANUWAVE HEALTH INC

SNWVNASDAQ

🏆 #3553 by market capEarnings Nov 6US Equity

$5.55▼ $0.17 (−3.14%)

Market closed · at close

1h—

24h▼ 3.1%

7d▼ 6.5%

14d▼ 14.6%

30d▼ 50.3%

1y▼ 86.5%

🏦Market Cap

$48M

Small Cap

📈Revenue Growth (YoY)

+22.5%

Healthy

📊Gross Margin

76.7%

High

💵FCF Margin

9.1%

Moderate

⚖️P/S Ratio

1.1x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $5.49 – $5.59
52-Week Range: $5.27 – $46.59
Volume: $3.04B
Avg Volume: $2.05B
Shares Outstanding: 8.6M
Next Earnings: Oct 27, 2026

Fundamentals Snapshot

Annual Revenue: $44M
Last Q Revenue: $10M
P/E Ratio: 3.1
P/S Ratio: 1.1x
EPS (TTM): $1.77
Dividend Yield: —

Why Investors Own SNWV

✓High-growth profile — revenue up +1.4% YoY with expanding US Equity exposure.
✓Healthy economics — 28% gross margin and 7% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$44M▲ +4.9% YoY

Gross Margin (TTM)

28.4%▲ +0.4% YoY

Operating Income (TTM)

$5M▲ +4.9% YoY

Free Cash Flow (TTM)

$3M▲ +4.9% YoY

About SANUWAVE HEALTH INC

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded on May 6, 2004 and is headquartered in Eden Prairie, MN.

🦦